Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Jade Biosciences Inc., 3 years.
Jade Biosciences Inc.
Director
Puma Biotechnology Inc
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Puma Biotechnology Inc June 11, 202698.8%
-
Puma Biotechnology Inc June 11, 202599.2%
-
Puma Biotechnology Inc June 18, 202497.2%
-
Puma Biotechnology Inc June 13, 202397.9%
-
Jade Biosciences Inc. June 6, 202398.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 2026 | Puma Biotechnology Inc | Open-market sale | −11,610 | $7.20 | $83,592 |
| Jun 11, 2026 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
| Jun 13, 2025 | Puma Biotechnology Inc | Open-market sale | −11,610 | $3.40 | $39,474 |
| Jun 11, 2025 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
| Jun 18, 2024 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
| Jun 13, 2024 | Puma Biotechnology Inc | Open-market sale | −11,000 | $3.37 | $37,070 |
| Jun 13, 2023 | Puma Biotechnology Inc | Open-market sale | −10,000 | $3.45 | $34,500 |
| Jun 13, 2023 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.